课题基金 / 基金详情

Cell Therapy for the degenerating intervertebral discs

Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
批准号:
8010767
负责人:
YEJIA ZHANG
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

YEJIA ZHANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The trainee is a young physician with a strong basic science background. With the guidance of the rehabilitation scientist training program (RMSTP), she has designed a career path that brings together her scientific and clinical interests. Her research has attracted a considerable amount of positive attention in the field of rehabilitation. Seven full manuscripts resulted from this work: three have been published, one in press (see attached manuscript and letter), and three are in review. In addition, 15 abstracts have been presented at national and international meetings. The proposed research development plan will allow her to gain additional technical expertise under the guidance of seasoned scientists, and become an independent clinician-investigator. The trainee's research plan addresses an immensely important clinical problem, back pain. Although the etiology of back pain is most likely multi-factorial, intervertebral disc degeneration is perhaps causally associated with back pain. Biological treatment with a growth factor may promote matrix repair and restore physiological function. Cell-based gene therapy, which aims at the sustained release of growth factors, will be explored. This revised proposal contains new data further supporting the central hypothesis that cell therapy is likely to represent an effective tool for slowing or even reversing disc degeneration: i) Rabbit intervertebral disc (IVD) explants injected with allogenic rabbit articular chondrocytes transduced with Ad-hBMP-7 produce more hBMP-7 protein; ii) Rabbit IVD explants injected with articular chondrocytes expressing hBMP-7 accumulate more proteoglycans. Based on these findings, she proposes to study the effects of BMP-7 on degenerative rabbit intervertebral discs using the ex vivo gene transfer method. She has also performed a pilot in vivo study and transplanted allogenic rabbit articular chondrocytes into the degeneration rabbit IVD, demonstrating her ability to perform in vivo studies. Dr. Irving Shapiro, a disc biologist, has assumed the role of her primary mentor. The trainee's in vivo study will also be helped by Dr. D. Greg Anderson, a spine surgeon,with extensive experience with the animal disc injury model. In the revised training plan, the trainee proposes to participate in course work and to learn additional techniques. Thomas Jefferson University provides a rich environment, and has a strong commitment to support her career development.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/jor.22787
发表时间: 2015-04
期刊: Journal of orthopaedic research : official publication of the Orthopaedic Research Society
影响因子: --
作者: [Scanzello CR, Markova DZ, Chee A, Xiu Y, Adams SL, Anderson G, Zgonis M, Qin L, An HS, Zhang Y]
通讯作者: Zhang Y
DOI: 10.1097/phm.0b013e31817c1945
发表时间: 2008-09
期刊: American journal of physical medicine & rehabilitation
影响因子: 3
作者: [Yejia Zhang;H. An;C. Tannoury;E. Thonar;M. Freedman;D. Anderson]
通讯作者: Yejia Zhang;H. An;C. Tannoury;E. Thonar;M. Freedman;D. Anderson
Cell therapy using articular chondrocytes overexpressing BMP-7 or BMP-10 in a rabbit disc organ culture model.
在兔椎间盘器官培养模型中使用过表达 BMP-7 或 BMP-10 的关节软骨细胞进行细胞治疗。
DOI: 10.1097/brs.0b013e31816b1f38
发表时间: 2008
期刊: Spine
影响因子: 3
作者: [Zhang,Yejia, Phillips,FrankM, Thonar,EugeneJ-MA, Oegema,Theodore, An,HowardS, Roman-Blas,JorgeA, He,Tong-Chuan, Anderson,DGreg]
通讯作者: Anderson,DGreg
DOI: 10.1097/brs.0b013e3181f60b39
发表时间: 2011-09-01
期刊: Spine
影响因子: 3
作者: [Zhang Y, Drapeau S, An HS, Markova D, Lenart BA, Anderson DG]
通讯作者: Anderson DG
11
    Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
    • 批准号:
      10448429
    • 项目类别:
    • 资助金额:
      $17.25万
    • 财政年份:
      2021
    • 负责人:
      YEJIA ZHANG
    • 依托单位:
    Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
    • 批准号:
      10301274
    • 项目类别:
    • 资助金额:
      $21.01万
    • 财政年份:
      2021
    • 负责人:
      YEJIA ZHANG
    • 依托单位:
    Cell Therapy for the Degenerating Intervertebral Disc
    • 批准号:
      9032599
    • 项目类别:
    • 资助金额:
      $0.0万
    • 财政年份:
      2015
    • 负责人:
      YEJIA ZHANG
    • 依托单位:
    Cell Therapy for the degenerating intervertebral discs
    • 批准号:
      7687031
    • 项目类别:
    • 资助金额:
      $4.65万
    • 财政年份:
      2007
    • 负责人:
      YEJIA ZHANG
    • 依托单位:
    海外基金